Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-04T18:02:18.536Z Has data issue: false hasContentIssue false
  • English
  • Français

Recommendations for Preventing the Spread of Vancomycin Resistance

Published online by Cambridge University Press:  02 January 2015

Hospital Infection Control Practices Advisory Committee (HICPAC)
Get access Rights & Permissions [Opens in a new window]

Summary

A rapid increase in the incidence of infection and colonization with vancomycin-resistant enterococci (WE) has been reported from U.S. hospitals in the last 5 years. This increase poses several problems, including: a) the lack of available antimicrobials for therapy of infections due to VRE, since most VRE are also resistant to multiple other drugs, e.g., aminoglycosides and ampicillin, previously used for the treatment of infections due to these organisms, and b) the possibility that the vancomycin resistance genes present in VRE may be transferred to other gram-positive microorganisms such as Staphylococcus aureus.

An increased risk of VRE infection and colonization has been associated with previous vancomycin and/or multi-antimicrobial therapy, severe underlying disease or immuno-suppression, and intra-abdominal surgery. Because enterococci can be found in the normal gastrointestinal or female genital tract, most enterococcal infections have been attributed to endogenous sources within the individual patient. However, recent reports of outbreaks and endemic infections due to enterococci, including VRE, have shown that patient-to-patient transmission of the microorganisms can occur either via direct contact or indirectly via hands of personnel or contaminated patientcare equipment or environmental surfaces.

Prevention and control of the spread of vancomycin resistance will require coordinated, concerted effort from various departments of the hospital, and can only be achieved if each of the following elements is addressed: 1) prudent vancomycin use by clinicians, 2) education of hospital staff regarding the problem of vancomycin resistance, 3) early detection and prompt reporting of van-comycin resistance in enterococci and other gram-positive microorganisms by the hospital microbiology laboratory, and 4) immediate implementation of appropriate infection-control measures to prevent person-to-person transmission of VRE.

Type
Special Report
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 2 , February 1995 , pp. 105 - 113
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention, Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR 1993;42:597–599.Google Scholar
2. Rubin, LG, Tucci, V, Cercenado, E, Eliopoulos, G, Isenberg, HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-705.10.1086/648342CrossRefGoogle Scholar
3. Karanfil, LY Murphy, M, Josephson, A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195–200.10.1086/646509CrossRefGoogle Scholar
4. Handwerger, S, Raucher, B, Altarac, D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750–755.10.1093/clind/16.6.750CrossRefGoogle ScholarPubMed
5. Frieden, TR. Munsiff, SS. Low, DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76–79.10.1016/0140-6736(93)91285-TCrossRefGoogle ScholarPubMed
6. Boyle, JF Soumakis, SA, Rendo, A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280–1285.10.1128/jcm.31.5.1280-1285.1993CrossRefGoogle ScholarPubMed
7. Montecalvo, MA, Horowitz, H, Gedris, C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Entero-coccus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363–1367.10.1128/AAC.38.6.1363CrossRefGoogle Scholar
8. Boyce, JM, Opal, SM, Chow, JW, et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable van B class vancomycin resistance. J Clin Microbiol 1994;32:1148–1153.10.1128/jcm.32.5.1148-1153.1994CrossRefGoogle Scholar
9. Tenover, FC, Tokars, J, Swenson, J, Paul, S, Spitalny, K, Jarvis, W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993;31:1695–1699.10.1128/jcm.31.7.1695-1699.1993CrossRefGoogle ScholarPubMed
10. Sahm, DF, Olsen, L. In vitro detection of enterococcal vancomycin resistance. Antimicrob Agents Chemother 1990;34:1846–1848.10.1128/AAC.34.9.1846CrossRefGoogle ScholarPubMed
11. Zabransky, RJ, Dinuzzo, AR, Huber, MB, Woods, GL. Detection of vancomycin resistance in enterococci by the Vitek AMS System. Diagn Microbiol Infect Dis 1994;20:113–116.10.1016/0732-8893(94)90102-3CrossRefGoogle ScholarPubMed
12. Moellering, RC Jr. The Garrod lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991;28:1–12.10.1093/jac/28.1.1CrossRefGoogle ScholarPubMed
13. Hayden, MK, Koenig, Gl, Trenholme, GM. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrob Agents Chemother 1994;38:1225–1229.CrossRefGoogle ScholarPubMed
14. Mobarakai, N, Landman, D, Quale, JM. In-vitro activity of trospec-tomycin, a new aminocyclitol antibiotic against multidrug-resistant Enterococcus faecium . J Antimicrob Chemother 1994;33:319–321.10.1093/jac/33.2.319CrossRefGoogle ScholarPubMed
15. Murray, BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.10.1128/CMR.3.1.46CrossRefGoogle Scholar
16. Rhinehart, E, Smith, N, Wennersten, C, et al. Rapid dissemination of beta-lactamase-producing aminoglycoside-resistant Enterococcus faecium . N Engl J Med 1990;323:1814–1818.10.1056/NEJM199012273232606CrossRefGoogle Scholar
17. Livornese, LL Jr. Dias, S. Samel, C. et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.10.7326/0003-4819-117-2-112CrossRefGoogle ScholarPubMed
18. Uttley, AH, George, RC, Naidoo, J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173–181.10.1017/S0950268800030478CrossRefGoogle ScholarPubMed
19. Leclercq, R, Derlot, E, Weber, M, Duval, J, Courvalin, P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium . Antimicrob Agents Chemother 1989;33:10–15.10.1128/AAC.33.1.10CrossRefGoogle ScholarPubMed
20. Noble, WC. Virani, Z. Cree, R. Cotransfer of vancomycin and other resistance' genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus . FEMS Microbiol lett 1992;93:195–198.CrossRefGoogle Scholar
21. Veach, LA, Pfaller, MA, Barrett, M, Koontz, FP, Wenzel, RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 1990;28:2064–2068.10.1128/jcm.28.9.2064-2068.1990CrossRefGoogle ScholarPubMed
22. Degener, JE, Heck, MEOC, Vanleeuwen, WJ, et al. Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiologic study. J Clin Microbiol 1994;32:2260–2265.10.1128/jcm.32.9.2260-2265.1994CrossRefGoogle Scholar
23. Small, PM, Chambers, HF, Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227–1231.10.1128/AAC.34.6.1227CrossRefGoogle ScholarPubMed
24. Cantoni, L, Glauser, MP, Bille, J. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Antimicrob Agents Chemother 1990;34:2348–2353.10.1128/AAC.34.12.2348CrossRefGoogle ScholarPubMed
25. American Heart Association Committee on Rheumatic Fever and Infective Endocarditis. Prevention of bacterial endocarditis. Circulation 1984;70:1123–1124.Google Scholar
26. Maki, DG. Bohn, MJ, Stolz, SM. Kroncke, GM. Acher, CW. Myerowitz, PD. Comparative study of cefazolin, cefamandole; and vancomycin for surgical prophylaxis in cardiac and vascular operations. J Thorac Cardiovasc Surg 1992; 104:1432–1434.10.1016/S0022-5223(19)34639-2CrossRefGoogle ScholarPubMed
27. Classen, DC, Evans, RS, Pestotnik, SL, Horn, SD, Menlove, RL, Burke, JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281–286.CrossRefGoogle ScholarPubMed
28. Conte, JE Jr, Cohen, SN, Roe, BB, et al. Antibiotic prophylaxis and cardiac surgery A prospective double-blind comparison of single-dose versus multiple-dose regimens. Ann Intern Med 1972;76:943.10.7326/0003-4819-76-6-943CrossRefGoogle ScholarPubMed
29. DiPiro, JX Cheung, RPF Bowden, TA, et al. Single-dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986;152:552.10.1016/0002-9610(86)90228-XCrossRefGoogle ScholarPubMed
30. Heydemann, JS, Nelson, CL. Short-term preventive antibiotics. Clin Orthop 1986;205:184–187.10.1097/00003086-198604000-00022CrossRefGoogle Scholar
31. Rubin, M, Hathom, JW, Marshall, D, Gress, J, Steinberg, S, Pizzo, PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988;108:30–35.10.7326/0003-4819-108-1-30CrossRefGoogle ScholarPubMed
32. Shenep, JL, Hughes, WT, Roberson, PK, et al. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile neutropenic children with cancer. N Engl J Mei 1988;319:1053–1058.10.1056/NEJM198810203191604CrossRefGoogle ScholarPubMed
33. Pizzo, PA, Hathorn, JW, Hemenz, J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552–558.10.1056/NEJM198608283150905CrossRefGoogle ScholarPubMed
34. Karp, JE, Dick, JD, Angelopulos, C, et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Am J Med 1986;81:237–242.CrossRefGoogle ScholarPubMed
35. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, National Cancer Institute of Canada Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991;163:951–958.10.1093/infdis/163.5.951CrossRefGoogle Scholar
36. Riikonen, P. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 1991;10:918–923.Google ScholarPubMed
37. Lamy, T, Michelet, C, Dauriac, C, Gulois, I, Donio, PY, Le Prise, PY. Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenicpatients: aprospective, randomizedttialamong 59 patients. Acta Haematol 1993;90:109–113.10.1159/000204389CrossRefGoogle Scholar
38. Isaacman, MJ, Karasic, RS. Lack of effect of changing needles on contamination of blood culture. Pediatr Infect Dis J 1990;9:274–278.10.1097/00006454-199004000-00010CrossRefGoogle Scholar
39. Krumholz, HN, Cummings, S, York, M. Blood culture phlebotomy: switching needles does not prevent contamination. Ann Intern Mei 1990;113:290–292.CrossRefGoogle Scholar
40. Strand, CL, Wajsbort, RR, Sturmann, K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA 1993;269:1004–1006.CrossRefGoogle ScholarPubMed
41. Maki, DG, Schuma, AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978;275:271–282.10.1097/00000441-197805000-00005CrossRefGoogle ScholarPubMed
42. Ranson, MR. Oppenheim, BA Jackson, A. Kamthan, AG. Scarffe, JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15:95–102.10.1016/0195-6701(90)90025-JCrossRefGoogle ScholarPubMed
43. Hendrickson, KJ, Posell, KR, Schwartz, CL. A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities . J Infect Dis 1989;157:600–601.CrossRefGoogle Scholar
44. Schwartz, CL, Hendrickson, KJ, Roghmann, K, Posell, K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organism. J Clin Oncol 1990;8:1591–1597.10.1200/JCO.1990.8.9.1591CrossRefGoogle Scholar
45. Hendrickson, KJ, Dunne, WM. Modification of central venous catheter flush solution improves in vitro antimicrobial activity. J Infect Dis 1992;166:944–946.10.1093/infdis/166.4.944CrossRefGoogle Scholar
46. Gaillard, I, Merlino, R, Pajot, N, et al. Conventional and noncon-ventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. J Parenter Enteral Nutr 1990;14:593–597.10.1177/0148607190014006593CrossRefGoogle ScholarPubMed
47. Spafford, PS, Sinkin, RA, Cox, C, Reubens, L, Powell, KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Peiiatr 1994;125:259–263.Google ScholarPubMed
48. Kaplan, AH, Gffligan, PH, Facklam, RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988;26:1216–1218.10.1128/jcm.26.6.1216-1218.1988CrossRefGoogle ScholarPubMed
49. Gradon, JD, Wu, EH, Lutwick, LI. Aerosolized vancomycin therapy facilitating nursing home placement. Ann Pharmacotker 1992;26:209–210.10.1177/106002809202600214CrossRefGoogle ScholarPubMed
50. Weathers, J, Riggs, D, Santeiro, M, Weibley, RE. Aerosolized vancomycin for treatment of airway colonization by methicillin-resistant Staphylococcus aureus . Pediatr Infect Dis 1990;9:220–221.CrossRefGoogle ScholarPubMed
51. Johnson, S, Homann, SR, Bettin, KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. Ann Intern Med 1992;117:297–302.10.7326/0003-4819-117-4-297CrossRefGoogle ScholarPubMed
52. Kacica, MS, Horgan, MJ, Ochoa, L, Sandler, R, Lapow, ML, Venezia, RA Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994;125:253–258.CrossRefGoogle ScholarPubMed
53. Lam, TY, Vas, SI, Oreopoulos, DG. Long-term intraperitoneal vancomycin in the prevention of recurrent peritonitis during continuous ambulatory peritoneal dialysis: preliminary results. Perit Dial Int 1991;11:281–282.CrossRefGoogle ScholarPubMed
54. Bestani, B, Freer, K, Read, D, et al. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients. Nephron 1987;45:283–285.10.1159/000184164CrossRefGoogle Scholar
55. Newman, LN, Tessman, M, Hanslik, T Schulak, J, Mayes, J, Friedlander, M. A retrospective view of factors that affect catheter healing: four years of experience. Adv Perit Dial 1993;9:217–222.Google ScholarPubMed
56. Capdevilla, JA, Segarra, A, Planes, AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrology Dialysis Transplantation 1993;8:231–234.Google Scholar
57. Edell, LS, Westby, GR, Gould, SR. An improved method of vancomycin administration to dialysis patients. Clin Nephrol 1988;29:86–87.Google ScholarPubMed
58. Soumerai, SB, McLaughlin, TJ, Avorn, J. Quality assurance for drug prescribing. Qual Assur Health Care 1990;2:37–58.CrossRefGoogle ScholarPubMed
59. Everitt, DE, Soumerai, SB, Avorn, J, Klapholz, H, Wessels, M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol 1990;11:578–583.10.1086/646098CrossRefGoogle ScholarPubMed
60. Soumerai, SB, Avorn, J, Taylor, WC, Wessels, M, Maher, D, Hawley, SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Medical Care 1993;31:552–558.10.1097/00005650-199306000-00009CrossRefGoogle Scholar
61. Soumerai, SB, McLaughlin, TJ, Avom, J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989:67:268–317.CrossRefGoogle ScholarPubMed
62. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Publication M7-A3. 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.Google Scholar
63. Swenson, JM, Ferrara, MJ, Sahm, DE, Charache, P. The National Committee for Clinical Laboratory Standards Working Group on Enterococci, Tenover FC. New vancomycin disk diffusion breakpoints for enterococci. J Clin Microbiol 1992;30:2525–2528.CrossRefGoogle Scholar
64. Centers for Disease Control. Recommendations for prevention of LUV transmission in health-care settings. MMWR 1997;36:3S–18S.Google Scholar
65. Swenson, JM, Clark, NC, Ferraro, MJ, et al. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 1994;32:1700–1704.10.1128/jcm.32.7.1700-1704.1994CrossRefGoogle ScholarPubMed
66. Edberg, SC, Hardalo, CJ, Kontnick, C, Campbell, S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol 1994;32:2182–2184.10.1128/jcm.32.9.2182-2184.1994CrossRefGoogle ScholarPubMed
67. Nettleman, MD, Trilla, A, Fredrickson, M, Pfaller, M. Assigning responsibility: using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus . Am J Med 1991;91(suppl 3B):228S–232S.10.1016/0002-9343(91)90373-6CrossRefGoogle ScholarPubMed
68. Zervos, MJ, Kauffman, CA. Therasse, PM. Bergman, AG. Mikesell, TS, Schaberg, DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987;106:687–691.CrossRefGoogle ScholarPubMed
69. Doebbeling, BN, Stanley, GL, Sheetz, GL, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.CrossRefGoogle ScholarPubMed
70. Jones, MV, Rowe, GB, Jackson, B, Pritchard, NJ. The use of alcohol paper wipes for routine hand cleansing: results of trials in two hospitals. J Hosp Infect 1986;8:268–274.CrossRefGoogle ScholarPubMed
71. Nicoletti, G, Boghossian, V, Borland, R Hygienic hand disinfection: a comparative study with Chlorhexidine detergents and soap. J Hosp Infect 1990;15:323–337.10.1016/0195-6701(90)90089-7CrossRefGoogle ScholarPubMed
72. Bute, AM, Laughon, BE, Cullette, DL, Larson, EL. Alcohol-impregnated wipes as an alternative in hand hygiene. Am J Infect Control 1990;18:70–76.Google Scholar
73. Korniewicz, DM, Laughon, BE, Bute, A, Larson, E. Integrity of vinyl and latex procedure gloves. Nurs Res 1989;38:144–146.CrossRefGoogle ScholarPubMed
74. Korniewicz, DM, Kirwin, M, Cresci, K, et al. In-use comparison of latex gloves in two high-risk units: surgical intensive care and acquired immunodeficiency syndrome. Heart Lung 1992;21:81–84.Google ScholarPubMed
75. DeGroot-Kosolcharoen, J, Jones, JM. Permeability of latex and vinyl gloves to water and blood. Am J Infect Control 1989;17:196–201.CrossRefGoogle ScholarPubMed
76. Paulssen, J, Eidem, T, Kristiansen, R. Perforations in surgeons' gloves. J Hosp Infect 1988;11:82–85.10.1016/0195-6701(88)90043-6CrossRefGoogle ScholarPubMed
77. Korniewicz, DM, Laughon, BE, Cyr, WH, et al. Leakage of virus through used vinyl and latex examination gloves J Clin Microbiol 1990;28:787–788.CrossRefGoogle ScholarPubMed
78. Wade, JJ, Desai, N, Casewell, MW. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus fae-cium and gentamicin-resistant Enterobacter cloacae . J Hosp Infect 1991;18:211–218.CrossRefGoogle ScholarPubMed
79. Favero, MS, Bond, WW. Sterilization, disinfection, and antisepsis in the hospital. In: Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology; 1991:183–200.Google Scholar
80. Wells, VD, Wong, ES, Murray, BE, Coudron, PE, Williams, DS, Markowite, SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis . Ann Intern Med 1992;116:285–292.CrossRefGoogle ScholarPubMed
81. Orgberg, PK, Sandine, WE. Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp. Appl Environ Microbiol 1984;48:1129–1133.CrossRefGoogle Scholar
82. Schwalbe, RS, Ritz, WJ, Verma, PR, Barranco, EA Gilligan, PH. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus . J Infect Dis 1990;161:45–51.CrossRefGoogle ScholarPubMed
83. Garner, JS, Simmons, BP. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1983;4(suppl):245-325.Google Scholar